Biomaterials for Craniofacial Bone Regeneration

https://doi.org/10.1016/j.cden.2017.06.003Get rights and content

Section snippets

Key points

  • Calcium phosphate bioceramics remain some of the most widely used biomaterials for bone regeneration, particularly because of their long clinical track-record and well-studied mechanisms.

  • Both natural and synthetic polymers, despite their comparatively low rigidity, offer a range of physical and biologic advantages over bioceramics, such as the possibility of controlling 3D cellular microenvironments for stem cell differentiation and tissue regeneration.

  • Biomaterials are synthesized and/or

Calcium Phosphate Scaffolds and Cements

Bioceramics, such as CaP, calcium carbonates, calcium sulfates, bioactive glasses, and composite materials combining bioactive inorganic materials with biodegradable polymers are some of the most promising biomaterials for application in bone regeneration.4 Research concerning the ability of CaP bioceramics to stimulate bone growth date back to the 1920s, when an aqueous slurry of “triple CaP” was used to enhance bone formation.5 Especially since the establishment of tissue engineering as a

Natural Polymers

Organic scaffolds, such as polymer hydrogels, find use in the delivery of cells and/or GFs for bone regeneration because of their cytocompatibility, ability to stimulate an appropriate cellular response, porosity, and controlled degradability under physiologic conditions. Biopolymers of natural origin, such as collagen, gelatin, chitosan, and silk, are used for this purpose because they mimic the structure, chemical composition, and biochemical properties of the natural bone organic matrix;

Biomaterials for controlled delivery

A synergistic combination of cells, proteins, genes, and biophysical signals is critical to trigger functional bone regeneration. In the native tissue milieu, the local presentation and spatiotemporal distribution of these combinatorial factors are highly orchestrated by ECM components. This native complex microenvironment has inspired the design and development of biomimetic and biodegradable material carriers possessing ECM-like properties for the controlled delivery and retention of

3D printing and bioprinting

The rapid expansion of 3D printing in the past 5 years has had a considerable and immediate impact in the area of craniofacial bone augmentation. 3D printing addresses a series of significant challenges that up to now have prevented bone tissue engineering from being translated into clinical practice. The benefits of 3D printing include the ability to control the internal and external 3D architecture of scaffold systems, the ease of fabrication of scaffolds that precisely match patient-specific

Summary

Several decades of intense research have yielded a new generation of biomaterials and novel design strategies with limitless benefits of incorporating cells, drugs, and other biochemical signals to promote the formation of engineered bone tissue. With the latest advent of 3D biofabrication technologies, the future of craniofacial reconstruction will witness patient-specific surgical implants for large-volume bone defects that can fully vascularize and rapidly integrate with the supporting host

Acknowledgments

The authors acknowledge funding from the National Institute of Dental and Craniofacial Research, National Institutes of Health (R01DE026170 to LEB), and the Medical Research Foundation of Oregon (to LEB).

First page preview

First page preview
Click to open first page preview

References (138)

  • L. Wang et al.

    Thermogelling chitosan and collagen composite hydrogels initiated with beta-glycerophosphate for bone tissue engineering

    Biomaterials

    (2010)
  • L. Uebersax et al.

    Biocompatibility and osteoconduction of macroporous silk fibroin implants in cortical defects in sheep

    Eur J Pharm Biopharm

    (2013)
  • Y. Zhang et al.

    The osteogenic properties of CaP/silk composite scaffolds

    Biomaterials

    (2010)
  • A. Mata et al.

    Bone regeneration mediated by biomimetic mineralization of a nanofiber matrix

    Biomaterials

    (2010)
  • T.C. Holmes

    Novel peptide-based biomaterial scaffolds for tissue engineering

    Trends Biotechnol

    (2002)
  • N.R. Gandavarapu et al.

    Extracellular matrix protein adsorption to phosphate-functionalized gels from serum promotes osteogenic differentiation of human mesenchymal stem cells

    Acta Biomater

    (2013)
  • M.J. Sawkins et al.

    Hydrogels derived from demineralized and decellularized bone extracellular matrix

    Acta Biomater

    (2013)
  • A. Kolk et al.

    Current trends and future perspectives of bone substitute materials: from space holders to innovative biomaterials

    J Craniomaxillofac Surg

    (2012)
  • E. Gruskin et al.

    Demineralized bone matrix in bone repair: history and use

    Adv Drug Deliv Rev

    (2012)
  • D.J. Holt et al.

    Demineralized bone matrix as a vehicle for delivering endogenous and exogenous therapeutics in bone repair

    Adv Drug Deliv Rev

    (2012)
  • T.J. Nash et al.

    Effect of platelet-derived growth factor on tibial osteotomies in rabbits

    Bone

    (1994)
  • T.L. Aghaloo et al.

    Investigation of platelet-rich plasma in rabbit cranial defects: a pilot study

    J Oral Maxillofac Surg

    (2002)
  • J. Choukroun et al.

    Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift

    Oral Surg Oral Med Oral Pathol Oral Radiol Endod

    (2006)
  • E.H. Lee et al.

    A combination graft of low-molecular-weight silk fibroin with Choukroun platelet-rich fibrin for rabbit calvarial defect

    Oral Surg Oral Med Oral Pathol Oral Radiol Endod

    (2010)
  • E. Anitua et al.

    New insights into and novel applications for platelet-rich fibrin therapies

    Trends Biotechnol

    (2006)
  • T. Wang et al.

    Osteoinduction and proliferation of bone-marrow stromal cells in three-dimensional poly (epsilon-caprolactone)/hydroxyapatite/collagen scaffolds

    J Transl Med

    (2015)
  • G.Q. Chen et al.

    The application of polyhydroxyalkanoates as tissue engineering materials

    Biomaterials

    (2005)
  • C. Doyle et al.

    In vitro and in vivo evaluation of polyhydroxybutyrate and of polyhydroxybutyrate reinforced with hydroxyapatite

    Biomaterials

    (1991)
  • M.D. Timmer et al.

    Fabrication of poly(propylene fumarate)-based orthopaedic implants by photo-crosslinking through transparent silicone molds

    Biomaterials

    (2003)
  • S. Fu et al.

    Injectable and thermo-sensitive PEG-PCL-PEG copolymer/collagen/n-HA hydrogel composite for guided bone regeneration

    Biomaterials

    (2012)
  • V. Tollemar et al.

    Stem cells, growth factors and scaffolds in craniofacial regenerative medicine

    Genes Dis

    (2016)
  • X. Duan et al.

    VEGF stimulates intramembranous bone formation during craniofacial skeletal development

    Matrix Biol

    (2016)
  • H.S. Azevedo et al.

    Biomimetic supramolecular designs for the controlled release of growth factors in bone regeneration

    Adv Drug Deliv Rev

    (2015)
  • S.H. Lee et al.

    Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering

    Adv Drug Deliv Rev

    (2007)
  • Z.S. Patel et al.

    Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model

    Bone

    (2008)
  • W.J. King et al.

    Growth factor delivery: how surface interactions modulate release in vitro and in vivo

    Adv Drug Deliv Rev

    (2012)
  • R.G. Triplett et al.

    Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation

    J Oral Maxillofac Surg

    (2009)
  • C. Strobel et al.

    Sequential release kinetics of two (gentamicin and BMP-2) or three (gentamicin, IGF-I and BMP-2) substances from a one-component polymeric coating on implants

    J Control Release

    (2011)
  • M. Mehta et al.

    Biomaterial delivery of morphogens to mimic the natural healing cascade in bone

    Adv Drug Deliv Rev

    (2012)
  • R. Langer et al.

    Tissue engineering

    Science

    (1993)
  • L.E. Bertassoni et al.

    Engineering mineralized and load bearing tissues

    (2015)
  • N. Annabi et al.

    25th anniversary article: rational design and applications of hydrogels in regenerative medicine

    Adv Mater

    (2014)
  • L.C. Gerhardt et al.

    Bioactive glass and glass-ceramic scaffolds for bone tissue engineering

    Materials

    (2010)
  • F.H. Albee

    Studies in bone growth: triple calcium phosphate as a stimulus to osteogenesis

    Ann Surg

    (1920)
  • S. Boonrungsiman et al.

    The role of intracellular calcium phosphate in osteoblast-mediated bone apatite formation

    Proc Natl Acad Sci U S A

    (2012)
  • S.V. Dorozhkin

    Calcium orthophosphates: occurrence, properties, biomineralization, pathological calcification and biomimetic applications

    Biomatter

    (2011)
  • L.C. Chow

    Solubility of calcium phosphates

  • S. Kamakura et al.

    Implanted octacalcium phosphate is more resorbable than beta-tricalcium phosphate and hydroxyapatite

    J Biomed Mater Res

    (2002)
  • T. Steffen et al.

    Porous tricalcium phosphate and transforming growth factor used for anterior spine surgery

    Eur Spine J

    (2001)
  • E. Munting et al.

    Bone repair of defects filled with a phosphocalcic hydraulic cement: an in vivo study

    J Mater Sci Mater Med

    (1993)
  • Cited by (100)

    View all citing articles on Scopus
    View full text